A flat weight trend does not identify its cause or tell you to increase a GLP-1 dose. First verify the measurements and timeline, then review medication, symptoms, nutrition, activity, and other health changes with your prescriber.
There is no universal number of flat weeks that defines a plateau for every person. Weight entries are affected by timing, clothing, measurement equipment, fluid balance, meals, and bowel movements. A trend view can summarize entries, but it cannot separate fat, lean tissue, and fluid.
Check the Record Before Interpreting It
Review these details:
- Are the dates and units correct?
- Were measurements collected under reasonably consistent conditions?
- Are there missing doses or uncertain medication entries?
- Did illness, vomiting, diarrhea, constipation, travel, or another medicine overlap?
- Did your activity, intake, or routine change?
Write “unknown” instead of reconstructing a dose from memory. A reliable timeline is more useful than a complete-looking one built from guesses.
A Dose Marker Is Context, Not Causation
The current Ozempic, Wegovy, Mounjaro, and Zepbound labels provide product-specific titration and maintenance instructions. Starting doses and intermediate doses are not interchangeable across brands or indications.
A flat chart at a given dose does not prove that the dose “stopped working,” and the next labeled dose does not promise that weight loss will resume. Bring the record to the prescriber who can consider response, tolerability, indication, and the label together. Never increase or space doses on your own to change the chart.
Use Trial Results as Context, Not a Target
In STEP 1, adults with overweight or obesity without diabetes received semaglutide 2.4 mg or placebo with lifestyle intervention for 68 weeks; the estimated mean changes were -14.9% and -2.4%, respectively. In SURMOUNT-1, adults with obesity or overweight without diabetes were assigned to specified tirzepatide doses or placebo for 72 weeks.
These are group results from separate studies. They do not establish a personal month-by-month curve, a minimum acceptable pace, or that a higher dose will restart loss. Comparing your chart directly with a trial average can hide important differences in population, medication, dose, and clinical support.
Topics to Discuss With Your Care Team
Depending on your history, a clinician or dietitian may review overall intake, protein adequacy, resistance exercise, sleep, symptoms, other medications, and medical conditions. Those are individualized assessments—not a universal “plateau-breaking” prescription.
Avoid aggressive restriction or a new workout plan solely because a line looks flat. Low intake, weakness, dizziness, vomiting, or dehydration are reasons to get clinical guidance. If weight monitoring is distressing or interacts with an eating-disorder history, tell your clinician and agree on a different monitoring plan.
How OffGrid Dose Can Help
OffGrid Dose places the weight and dose entries you provide on a timeline. That can make missing entries and event timing easier to review. It does not diagnose a plateau, calculate absorption, decide whether medication is effective, or recommend a dose.
The app stores its working data on your iPhone. There is no OffGrid Dose account, company-operated cloud sync, or server-side health database, so OffGrid Dose does not receive your weight or dose history. Depending on your Apple and device settings, an encrypted device backup may include app data.
Frequently Asked Questions
How long does a GLP-1 plateau last?
There is no universal duration. A flat set of measurements needs context, and its cause cannot be determined from time alone.
Should I increase my dose?
Do not increase it yourself. The prescriber should apply the current label to your indication, response, symptoms, and medical history.
Will more protein or exercise restart weight loss?
Nutrition and resistance exercise may be appropriate parts of a care plan, but they do not guarantee a change in the chart. Ask a qualified professional for targets suited to you.
Does changing injection sites break a plateau?
The labels direct users to rotate injection sites, but a site log cannot diagnose or correct a weight plateau. Follow your product's injection instructions and ask a clinician about any skin change or delivery concern.
This article is for educational purposes only and is not medical advice. Medication dosing and the evaluation of unexpected weight change belong with a qualified healthcare professional.
Related Articles
Track this with OffGrid Dose
Log every dose, rotate injection sites, and watch your weight trend in a private local working log.
Ozempic tracker →